In the Phase 2 data, nausea rates varied substantially by dose
Dose adjustments should be made based on target FPG, with the dose being titrated upwards or downwards by 2 Units every 34 days
L-carnitine is believed to work by altering insulin receptors and changing the expression of specific genes that regulate sugar metabolism
These are different symptoms with different clinical implications, and both should be interpreted transparently
if more than 3 days, skip that dose Daily GLP-1s: If you miss a dose, follow your PIL instructions If you take insulin or sulfonylureas alongside GLP-1 medications, do not adjust these doses yourself without medical advice, as this could increase hypoglycaemia risk Report persistent side effects to your GP rather than stopping treatment abruptly Some patients may require dose adjustment if they develop acute illness, undergo surgery, or experience significant changes in kidney function
Know that the insulin component creates hypoglycemia risk while the GLP-1 component causes gastrointestinal effects